RE:RE:I thought… Hmmmmm
when you have achieved a 30 year career studying Sepsis ( other than buying Spectral shares) and decide to leave your professorship position at a major US University, and have run several Trials on one of the most complex human conditions to try to resolve with a RCT, and are considered a Key Opinion Leader on the topic of Sepsis and blood perfusion world-wide ... THEN I will consider listening to you ...over the expert.
Until then you simply come across like a whiny child in the back seat, incapable of listening to reason when you find out from your father that the Chucky Cheese has suddenly closed due to a power outage, and you'll have to come back tomorrow.
While an unfortunate series of events has befallen the Tigris portion of the Trial, I believe that the BoD got the memo from serious ( and large) non-insider shareholders and that Mgt are making, and will be making, a sincere effort to improve things going forward ... towards an inevitable ( albeit somewhat delayed) endgame.
We demanded a thorough explanation, and I feel that we got one, including a discussion of new strategies being undertaken that will change the status quo ( pace of enrollment)
MM